Biozyma
Natural health product licensed in Canada
- Other names
- Biozyma Capsule
- Licence holder
- NuEra Nutraceutical Inc.
- NPN or DIN-HM
- 80131290
- Status
- Active licence
- Licence date
- 16 May 2024
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum - Cellule entière | 1,000,000,000 ufc | Not calculated |
| Bifidobacterium longum subsp. longum Source : BL88-Onlly | 1,000,000,000 ufc | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 300 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Aspergillus flavus var. oryzae - En entier | 15 mg | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 1,000,000,000 ufc | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : BL-516 | 1,000,000,000 ufc | Not calculated |
| Lactiplantibacillus plantarum Source : LP-Onlly | 1,000,000,000 ufc | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1,000,000,000 ufc | Not calculated |
| Lacticaseibacillus Casei Source : LC18 | 1,000,000,000 ufc | Not calculated |
| Lacticaseibacillus paracasei Source : LPC-28 | 1,000,000,000 ufc | Not calculated |
| Bifidobacterium breve Source : BB-8 | 1,000,000,000 ufc | Not calculated |
| Bifidobacterium breve Source : Bifidobacterium breve - Cellule entière | 1,000,000,000 ufc | Not calculated |
| Ligilactobacillus salivarius Source : LS-86 | 1,000,000,000 ufc | Not calculated |
| Limosilactobacillus Reuteri Source : LE-16 | 1,000,000,000 ufc | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 5,000 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 50 mg | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var. comosus - fruit | 450,000 FCC PU | Not calculated |
| Lacticaseibacillus Rhamnosus Source : LR22 | 1,000,000,000 ufc | Not calculated |
Non-medicinal ingredients
Eau purifiée, Dioxyde de titane, Stéarate de magnésium, Hydroxypropylméthylcellulose, Dioxyde de silicium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzyme.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80131290
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.